Key Findings: One of the key findings suggest that FAAH inhibitors and CBD can reduce cannabis use.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Denmark, United Kingdom, United States
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD), Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Citation: Rømer Thomsen K, et al. Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?. Neurosci Biobehav Rev. 2022; 132:169-180. doi: 10.1016/j.neubiorev.2021.11.033
Authors: Rømer Thomsen K, Thylstrup B, Kenyon EA, Lees R, Baandrup L, Feldstein Ewing SW, Freeman TP